Cerebral Venous Thrombosis and Activated Protein C Resistance
- 1 October 1996
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 27 (10), 1731-1733
- https://doi.org/10.1161/01.str.27.10.1731
Abstract
Background Activated protein C resistance (APC-R) due to factor V Leiden has recently been established as an important risk factor for cerebral venous thrombosis (CVT). The clinical significance of abnormal or borderline functional APC-R in the absence of factor V Leiden is uncertain. Our observations suggest that APC-R due to mechanisms other than factor V Leiden may also contribute to the development of CVT. Case Descriptions We describe three women who had superior sagittal and lateral sinus thrombosis while taking oral contraceptives and had a number of additional risk factors for CVT. Each had APC-R for different reasons. Conclusions Inherited thrombophilia, including APC-R, should be looked for in all patients with CVT. Functional APC-R is a highly prevalent coagulopathy, but the reasons for this abnormality are diverse; abnormal and borderline functional APC-R results should be supplemented by DNA analysis for the presence of factor V Leiden.Keywords
This publication has 6 references indexed in Scilit:
- Factor V R506Q Gene Mutation Analysis by PCR-RFLP:Optimization, Comparison With Functional Testing for Resistance to Activated Protein C, and Establishment of Cell Line ControlsAmerican Journal of Clinical Pathology, 1996
- New Molecular Insights into the Genetics of Thrombophilia. Resistance to Activated Protein C Caused by Arg506 to Gin Mutation in Factor V as a Pathogenic Risk Factor for Venous ThrombosisThrombosis and Haemostasis, 1995
- Modified APC resistance assay for patients on oral anticoagulantsThe Lancet, 1994
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Respiratory syncytial virus or influenza?The Lancet, 1993